Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2785–2808 of 17,780 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Hypertension
Interventions: Relaxation, RESPeRate; Behavioral · Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 80 Years
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: New Brunswick, New Jersey • New York, New York

Conditions: Music Therapy for Pain and Sedation
Interventions: provide headphones with music playing, Sounds; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Systemic Lupus Erythematosus (SLE)
Interventions: Health coach-led, online support program for people living with lupus; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Medication Abuse
Interventions: Clinical Decision Support (CDS) alerts; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 89 Years
Enrollment: 3,635 participants
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Wound; Hip
Interventions: STRATIFIX, VICRYL; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetes, Hypertension, Nutrition Poor
Interventions: Produce delivery, Cooking classes; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 64 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Fuchs Endothelial Corneal Dystrophy
Interventions: Ripasudil, Placebo; Drug
Lead sponsor: Kowa Research Institute, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 26
States / cities: Los Angeles, California • Palo Alto, California • Sacramento, California + 20 more

Conditions: Generalized Epidermolysis Bullosa Simplex
Interventions: AC-203, Vehicle; Drug
Lead sponsor: TWi Biotechnology, Inc.; Industry
Eligibility: 6 Months and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 7
States / cities: Rancho Santa Margarita, California • Stanford, California • Aurora, Colorado + 4 more

Conditions: Hypertension
Interventions: ASPIRE Intervention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Oak Lawn, Illinois

Conditions: Color Blindness, Color Vision Defects, Color Blindness, Green, Color Blindness, Red
Interventions: Experimental Group 1: Color Correcting Lenses, Placebo Group 1: Placebo Lenses, Placebo Group 1 Crosses over to become Experimental Group 2: Color Correcting Lenses, Experimental Group 1 Crosses over to become Placebo Group 2: Placebo Lenses, Color Correcting Lenses in Subjects with Normal Color Vision; Device
Lead sponsor: University of the Incarnate Word; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Pregnancy, Weight Gain
Interventions: behavioral intervention, Usual Prenatal Care; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: SIDS, Infant Development
Interventions: Safe; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: Up to 14 Days
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Cerebrovascular Accident
Interventions: Conventional hand exercise, MusicGlove, Conventional Arm Exercise, Resonating Arm Exerciser; Other · Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Irvine, California

Conditions: Laparoscopic Gastric Bypass, Obesity, Pain, Postoperative
Interventions: Ketamine, Narcotics, pain scale; Drug · Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Instructional Methods
Interventions: Conceptual teaching; Other
Lead sponsor: Sentara Norfolk General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Schizophrenia
Interventions: Iloperidone, Placebo; Drug
Lead sponsor: Vanda Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 635 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 28
States / cities: Anaheim, California • Bellflower, California • Costa Mesa, California + 22 more

Conditions: Sleep Quality, Sleep Health
Interventions: Sleep Supplement, Placebo; Dietary Supplement
Lead sponsor: 4Life Research, LLC; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Sandy City, Utah

Conditions: Alcohol Use Disorder, Contingency Management
Interventions: Standard care, Contingency management; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Advanced Solid Tumors
Interventions: Talazoparib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 7
States / cities: Fort Wayne, Indiana • Detroit, Michigan • Farmington Hills, Michigan + 2 more

Conditions: Cerebral Palsy (CP), Cerebral Palsy, Spasticity, Spasticity Due to Cerebral Palsy
Interventions: Constant Current Stimulator, Cadwell Guardian System; Device
Lead sponsor: Martin Piazza; Other
Eligibility: 3 Years to 14 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Prostate Cancer
Interventions: Yoga therapy; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 30 Years to 80 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Transplantation, Pediatric ALL
Interventions: myFAMI; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 100 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Suicidal Ideation, Suicide, Attempted, Coping Skills, Depression, Anxiety, PTSD
Interventions: Group Brief Cognitive-Behavioral Therapy (G-BCBT), Dialectical Behavior Therapy (DBT) Skills Group; Behavioral
Lead sponsor: University of North Carolina, Charlotte; Other
Eligibility: 18 Years to 99 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related Conditions, Vaginitis, Perimenopause
Interventions: Vaginal estradiol tablets, Vaginal moisturizer; Drug · Other
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: The Bronx, New York

Search by objective public record fields.

RCT of Effects of Device-guided Breathing on Ambulatory BP

Music Therapy is Associated With Decreased Pain and Agitation in Intubated ICU Patients

Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE

A Health System Wide Evaluation of Clinical Decision Support Tools to Improve PDMP Utilization and Patient Outcomes

Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.

The Produce Drop: Using Food as Medicine to Lower A1C Levels and Blood Pressure

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

ASPIRE: Adapting Self-Blood Pressure Monitoring to Reduce Health Disparities

Impact of Color Correcting Lenses on Color Vision Deficiency

Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain

Improving Infant Sleep Safety With the Electronic Health Record

Influence of Timing on Motor Learning

Ketamine vs Hydromorphone

A Study to Evaluate Strategies for Teaching Effective Use of Diagnostic Tests

Relapse Prevention Study in Patients With Schizophrenia

Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality

Dual Reinforcement Contingency Management for Alcohol Use Disorders

An Open-Label Pharmacokinetics and Safety Study of Talazoparib

Dorsal Root Electrical Stimulation in Children With Cerebral Palsy

Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy

mHealth Family Self-Management

The Group Risk Reduction Intervention Therapy (GRRIT) Project

Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV